| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 10,0 k € | -93.0% | 143,6 k € | +119.7% | 65,4 k € | +2034.8% | -3,4 k € | -102.1% | 162,5 k € | +3.2% | 157,4 k € | -18.8% | 193,8 k € | -10.1% | 215,6 k € | -21.6% | 275,0 k € | +4.4% | 263,3 k € | +26.8% | 207,7 k € | +9.2% | 190,2 k € | -21.2% | 241,5 k € | +66.6% | 144,9 k € | -36.4% | 227,8 k € | +5.5% | 216,0 k € | -5.8% | 229,2 k € | +201.9% | 75,9 k € | -58.4% | 182,5 k € | +16.7% | 156,3 k € | |
| EBITDA | 9,2 k € | -93.5% | 142,2 k € | +123.7% | 63,5 k € | +1359.9% | -5,0 k € | -103.1% | 160,2 k € | +3.3% | 155,2 k € | -18.5% | 190,3 k € | -11.2% | 214,4 k € | -21.6% | 273,3 k € | +4.4% | 261,8 k € | +27.0% | 206,1 k € | +9.7% | 187,9 k € | -21.3% | 238,7 k € | +66.4% | 143,4 k € | -36.4% | 225,4 k € | +4.9% | 215,0 k € | -5.6% | 227,7 k € | +210.8% | 73,3 k € | -59.5% | 180,8 k € | +17.0% | 154,5 k € | |
| Operating profit | 9,2 k € | -93.5% | 142,2 k € | +183.0% | 50,2 k € | +373.7% | -18,4 k € | -112.5% | 146,9 k € | +4.6% | 140,5 k € | -21.2% | 178,4 k € | -15.9% | 212,2 k € | -18.2% | 259,3 k € | +5.3% | 246,1 k € | +30.4% | 188,7 k € | +10.8% | 170,4 k € | -22.1% | 218,7 k € | +77.5% | 123,2 k € | +14.1% | 108,0 k € | -12.0% | 122,7 k € | -21.3% | 155,9 k € | +2701.2% | 5,6 k € | -95.7% | 129,3 k € | +22.2% | 105,8 k € | |
| Profit/loss | 11,4 k € | -90.4% | 118,9 k € | +196.5% | 40,1 k € | +45.8% | 27,5 k € | -73.4% | 103,5 k € | -4.1% | 107,9 k € | -10.7% | 120,8 k € | -16.1% | 144,0 k € | -7.3% | 155,4 k € | +4.3% | 149,0 k € | +38.8% | 107,3 k € | +0.7% | 106,5 k € | -32.0% | 156,7 k € | +91.9% | 81,6 k € | +11.7% | 73,1 k € | -13.7% | 84,7 k € | -23.2% | 110,4 k € | +766.3% | 12,7 k € | -86.0% | 91,3 k € | +27.4% | 71,7 k € | |
| Equity | 508,6 k € | +2.3% | 497,2 k € | +31.4% | 378,3 k € | +11.9% | 338,2 k € | -68.1% | 1,1 M € | +10.8% | 957,2 k € | +12.7% | 849,3 k € | +16.6% | 728,5 k € | +24.6% | 584,5 k € | +2.3% | 571,3 k € | +35.3% | 422,3 k € | +34.1% | 315,0 k € | +32.1% | 238,5 k € | -6.2% | 254,3 k € | +47.3% | 172,6 k € | +73.4% | 99,5 k € | -81.7% | 543,6 k € | +25.5% | 433,2 k € | +3.0% | 420,5 k € | +27.7% | 329,2 k € | |
| Total assets | 536,6 k € | +2.0% | 526,1 k € | +32.6% | 396,6 k € | +14.5% | 346,5 k € | -67.4% | 1,1 M € | +9.9% | 967,1 k € | +13.4% | 852,4 k € | +16.9% | 729,4 k € | -4.2% | 761,6 k € | +26.5% | 601,8 k € | +26.3% | 476,4 k € | +9.2% | 436,1 k € | -3.8% | 453,4 k € | +50.4% | 301,4 k € | +3.8% | 290,3 k € | -45.3% | 531,1 k € | -20.1% | 664,9 k € | +17.4% | 566,4 k € | -0.7% | 570,2 k € | +21.0% | 471,3 k € | |
| Cash | 177,4 k € | +98.1% | 89,6 k € | -16.6% | 107,4 k € | -5.4% | 113,5 k € | -23.3% | 148,0 k € | -4.5% | 155,0 k € | +757.1% | 18,1 k € | -37.7% | 29,0 k € | -32.0% | 42,7 k € | -51.9% | 88,8 k € | +138.3% | 37,3 k € | +180.0% | 13,3 k € | -87.3% | 104,9 k € | +50.3% | 69,8 k € | +4.7% | 66,6 k € | +245.4% | 19,3 k € | -48.2% | 37,3 k € | +59.9% | 23,3 k € | +6.1% | 22,0 k € | -45.8% | 40,5 k € | |
| Debts | 28,0 k € | -2.8% | 28,8 k € | +57.5% | 18,3 k € | +121.2% | 8,3 k € | +270.7% | 2,2 k € | -77.4% | 9,9 k € | +639.6% | 1,3 k € | +59.0% | 840,0 € | -99.5% | 177,0 k € | +487.3% | 30,1 k € | -43.3% | 53,2 k € | -55.7% | 120,0 k € | -43.7% | 213,2 k € | +382.1% | 44,2 k € | -61.7% | 115,5 k € | -73.2% | 430,4 k € | +257.9% | 120,3 k € | -9.3% | 132,5 k € | -11.0% | 149,0 k € | +5.6% | 141,1 k € | |
Private company with limited liability · Oostende · incorporated on 04/07/2001
Company — Voluntary dissolution - liquidation.
Private company with limited liability profitable and well capitalised. Cash position rising (+98.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. OMMESLAG DIRK is a Private company with limited liability incorporated in 2001. Its main activity is: Specialist medical practice activities. Its registered office is in Oostende.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette